-- Signature Underscores the Firm's Commitment to Sustainability & ESG Considerations --
Boulder, Colorado – November 14, 2019 – CRG, a premier healthcare-focused investment firm, today announced that it has signed the United Nations-supported Principles for Responsible Investment (PRI). The PRI is recognized as the leading global network for institutional asset owners and investors who have committed to integrating environmental, social, and governance (ESG) considerations into their investment decisions.
CRG believes that balancing ESG issues with financial priorities is fundamental to sound risk management and a core part of corporate responsibility. CRG has incorporated ESG principles into the firm’s…Read More »
New York, Jan. 16, 2019 /PRNewswire/ -- CRG, a premier healthcare-focused investment firm, today announced a $70 million commitment to Mid-Atlantic Dental Partners ("Mid-Atlantic), a dental support organization dedicated to improving the delivery of dental services for patients in several markets across the country and a portfolio company of S.C. Goldman & Company, LLC ("S.C. Goldman"). Mid-Atlantic recently completed the acquisition of Birner Dental Management Services, Inc. (OTCQX: BDMS), which operates dental practice affiliates under the Perfect Teeth brand throughout Colorado, Arizona, and New Mexico.
"By taking responsibility for all the non-clinical activities that go into running a dental practice, Mid-Atlantic has successfully partnered with dentists to…Read More »
New York, Nov. 26, 2018 /PRNewswire/ -- CRG, a premier healthcare-focused investment firm, today announced a $65 million commitment to HNI Healthcare ("HNI"), a technology-enabled physician practice management company focused on the delivery of full-service facility-based physician programs. HNI recently completed the acquisition of Martin Healthcare Group ("MHG"), a 40-year-old privately held company dedicated to the delivery of inpatient care and staffing solutions to acute and post-acute care hospitals across the Midwest and Florida.
"As the country's healthcare system continues its shift towards value-based care models, hospitals are being asked to deliver better outcomes at a lower cost," said Scott Li, Managing Director at CRG. "HNI's…Read More »
Boulder, Colorado - August 13, 2018 -- CRG, a premier healthcare-focused investment firm, today announced three firm-wide promotions, naming Scott Li as Managing Director, and appointing Zain Shekhani and Kevin Reilly as Vice President, effective immediately.
“We congratulate this high performing group of individuals and recognize their significant contributions to CRG’s ongoing success,” said Nate Hukill, Managing Partner and Chairman of CRG. “These promotions highlight our deep bench of world-class investing talent, enable our continued growth, and will help us efficiently deploy growth capital to more healthcare companies while generating strong risk-adjusted returns for our institutional partners.”
-- Provides CRG with additional leverage capacity and supports management's strategy of deploying capital to commercial-stage healthcare companies --
New York – June 26, 2018 – CRG, a premier healthcare-focused investment firm, today announced the closing of a $204 million financing on behalf of CRG Partners III, L.P. and certain of its parallel investment vehicles (collectively, “Fund III” or the “Fund”). The transaction was completed on June 25, 2018.
The securitization – or Asset-Backed Securities financing – is the third such financing completed by CRG since 2016 and reinforces CRG’s continued strong access to the capital markets. This…Read More »
New York – June 6, 2018 – CRG, a leading healthcare investment firm, today announced a partnership with Fast Pace Urgent Care (“Fast Pace”), a leading provider of urgent care clinics across rural Tennessee, Kentucky, and Mississippi, and its private equity sponsor Revelstoke Capital Partners (“Revelstoke”), a Denver-based private equity firm. The transaction resulted in a refinancing that provided additional capital for continued growth of Fast Pace.
“Fast Pace’s growing footprint and highly differentiated business model provide underserved rural populations with access to high quality, affordable healthcare,” said Scott Li, Principal at CRG. “The Company has a clear value…Read More »
Boulder, Colorado – May 1st, 2018 – CRG, a leading healthcare investment firm, today announced the appointment of Todd Holmes as Principal in the firm’s Boulder office. Mr. Holmes will join CRG’s investment team and help in all aspects of the investment process.
Mr. Holmes brings to CRG more than 14 years of experience sourcing, structuring, and executing investments in healthcare, biotechnology and life sciences companies. Most recently, Mr. Holmes was a founding member and Director at Gurnet Point Capital, a life sciences and healthcare-focused investment fund. Previously, Mr. Holmes was a Senior Associate at Third Rock Ventures, where…Read More »
-- Founder Charles Tate to serve as Chairman Emeritus --
Boulder, Colo. – April 18th, 2018 – CRG, a leading healthcare investment firm, today announced the completion of the transfer of control of the firm to Nathan Hukill, President and Chairman, effective March 31, 2018. In connection with the transfer, Charles Tate will retire from day-to-day operations of CRG and will serve as Chairman Emeritus of the company.
“This leadership transition ensures the long-term success of CRG and enables the current management team to continue executing its differentiated strategy of providing growth capital to commercial-stage healthcare companies and targeting…Read More »
-- Proceeds to be Used to Commercialize HEPLISAV-B™ [Hepatitis B Vaccine (Recombinant), Adjuvanted] in United States and Advance Company's Immuno-Oncology Product Candidates --
-- Company Deploying HEPLISAV-B Field Sales Team --
Berkeley, Calif., Feb. 20, 2018 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ:DVAX) today announced that it has closed on a $175 million non-dilutive term loan agreement with CRG LP, a healthcare focused investment firm. Dynavax will receive $100 million in a first tranche and up to an additional $75 million may be borrowed in a second tranche at Dynavax's option.
"This non-dilutive financing, together with our…Read More »
-- Continues momentum executing growth capital investment strategy to commercial-stage healthcare companies --
Boulder, Colo. – November 28, 2017 – CRG, a preeminent healthcare-focused investment firm, today announced cumulative financing commitments of $881 million in 11 new commercial-stage healthcare investments over the last 12 months. In addition, the firm generated realizations from eight portfolio company liquidity events during the same 12-month period, including M&A transactions and refinancing activities, resulting in a total of more than $425 million in proceeds to CRG and its institutional partners.
“We continue to selectively deploy the capital of our latest fund in commercial-stage…Read More »
New York, September 5, 2017 --Synergy Pharmaceuticals Inc. (NASDAQ: SGYP), announced today that the Company has closed on a $300 million debt financing structured as senior secured loans from CRG LP, a healthcare focused investment firm, and its lender syndicate.
“This non-dilutive financing enhances our cash position and provides us with financial flexibility to continue to execute on the launch of TRULANCE and achieve our business objectives, which we are confident will ultimately maximize long-term shareholder value,” said Gary Gemignani, EVP and Chief Financial Officer of Synergy Pharmaceuticals Inc. “The structure of this financing provides us with access to capital…Read More »
Houston – July 31, 2017 – CRG, a premier healthcare-focused investment firm, today announced the closing of a $355 million term loan securitization on behalf of CRG Partners III, L.P. and certain of its parallel investment vehicles. The transaction was completed on July 27, 2017.
The securitization transaction – or Asset-Backed Securities financing – is the second securitization completed by CRG and represents the latest milestone in CRG’s ability to deliver pioneering growth capital financing solutions to the global healthcare market. The financing consists of $355 million of notes that were sold through a private placement offering. The financing…Read More »
-- Financing Comprised of $50 Million Credit Facility and $3 Million Equity Investment --
-- Simultaneously Retiring Existing Debt --
-- Funds Received at Close Provide Sufficient Cash Under Current Operating Plan to Extend Cash Runway to Positive Cash Flow --
Dublin, Ireland and Trevose, Pa., July 17, 2017 (GLOBE NEWSWIRE) -- Strongbridge Biopharma plc, (Nasdaq:SBBP), a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, today announced that it has entered into a $50 million senior credit facility with CRG LP (“CRG”), a healthcare-focused investment firm, to retire its existing debt facility and provide additional capital for the Company. …Read More »
Earlens said today it closed a total of $118 million in funding, with $73 million coming from an offering of Series C preferred stock and $45 from a structured debt facility with CRG LP.
The Earlens device, which won 510(k) clearance from the FDA in October 2015, uses a laser diode attached to a behind-the-ear audio processor to transmit sound to the receiver against the patient’s eardrum, to directly contact the patient’s eardrum and use it as a speaker, the Menlo Park, Calif.-based company said.
“We are pleased to partner with CRG which has unrivaled healthcare investing expertise. This investment…Read More »
Vancouver, Canada, May 15, 2017 -- Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) ("Cardiome" or the "Company") today announced that it has amended its term loan agreement with CRG-managed funds (the "Amended Agreement") that was originally entered into on June 13, 2016. The Amended Agreement provides Cardiome with up to $50 million of available borrowing capacity.
William Hunter, M.D., President and CEO of Cardiome commented, “We are delighted to expand our agreement with CRG. We began our relationship under the premise that CRG would offer a platform to scale with Cardiome’s growing business, and we are pleased that…Read More »